Award
NIH Reporter #11065195
Podocyturia based assay as a predictive biomarker for systemic vascular diseases
Recipient
TEUCER DIAGNOSTICS, INC.
Award Amount
$306,101.00
Ceiling
$306,101.00
Awarded
April 16, 2025
Identifier
11065195
NIH/NHLBI awarded $306,101 to TEUCER DIAGNOSTICS, INC. for developing and validating a urinary biomarker assay to predict systemic vascular diseases, focusing on early cardiovascular disease detection.
Description
The project involves developing a point-of-care RT-PCR-based urinary biomarker assay to predict systemic vascular diseases, focusing on early detection of cardiovascular disease through podocyte-specific mRNA measurement in urine. The project aims to standardize and clinically validate the assay for reliability and reproducibility, with plans for Phase II clinical utility validation. The organization involved is TEUCER DIAGNOSTICS, INC., located in Omaha, NE.